Canadian Licensed Cannabis Producer


*Updated October 2, 2019*

PI Finacial gives Supreme Cannabis a strong BUY rating.

Price Target: $4.50 (25x EV/EBITDA)

Potential Upside: 220% + (12 month ROI)

Learn more about Supreme Cannabis (SPRWF): Website | Investor Deck

HQ: Toronto Canada
Incorporated: 1979 as Supreme Pharmaceuticals
Symbol: SPRWF (OTC)   FIRE (TSX)
Facilities: Kincardine, Ontario
Exchanges: TSX, OTC
Licenses: March 2016, 7Acres (subsidiary) received its production and sales licenses

Market Cap: $330 mil
Enterprise Value: $276 mil
Size within cannabis industry: about 14th of 200+
Size among cultivators: 13th of about 40
# of employees: NA

Markets: Strong
Primary: Near term, all Canada via wholesale markets and retail partners
Secondary: Long term, global markets where federally legal

Operations: Neutral to Good long term

Current production: 5,000 kgs/year
Future Capacity: 50,000 kgs/year production rate achieved in 2019

Distribution: Weak right now

Integration/Diversification: Weak
Vertically integrated: no
Horizontally diversified:  no

Financials: Weak right now (low)

Management: Neutral to Good

Branding: Neutral

Valuation: Neutral

Financings: Neutral to Good

Recommendation: Hold (March 31, 2019)